Articles Tagged With:
-
Zika Vaccine to Begin Phase I Clinical Trial
A Pennsylvania pharma company has developed the first vaccine to begin first-in-human testing.
-
The Vitals - June 2016
-
A Ray of Light in the Alzheimer’s Battle?
Tiny study cohort responds positively to comprehensive treatment regimen.
-
Gun Bills Stall in Senate
It's the latest in a string of gun control false starts.
-
Presenteeism: Working Sick Endangers Patients
In findings that further underscore the “presenteeism” phenomenon, investigators found that more than 40% of healthcare workers with influenza-like illness reported to work, putting patients and co-workers at risk of infection, an officer in the CDC Epidemic Intelligence Service recently reported at the annual EIS meeting in Atlanta.
-
Zika Testing: Virus Detection in Serum and Urine
More widespread testing for Zika virus is now available, as the FDA recently issued an Emergency Use Authorization for a Qualitative Real-Time RT-PCR test.
-
Group A Strep Outbreak Kills Four In Long-Term Care
An unusually large and persistent outbreak of Group A Streptococcus in a nursing home was spread in part by infected and colonized healthcare workers, underscoring the importance of reporting symptoms, seeking treatment, practicing rigorous infection control, and not working sick, an officer in the CDC Epidemic Intelligence Service recently reported at the annual EIS meeting in Atlanta.
-
WHO Convenes Zika Panel: Fate of the Olympics
Relenting to a growing chorus of international concern, the WHO will seek the opinion of a committee of infectious disease experts before it makes a final decision on allowing the Summer Olympics to be held in Rio de Janeiro.
-
Another Brick in the Wall: Colistin-resistant E.coli
The possible emergence of untreatable E. coli — a common cause of urinary tract and other infections in the community — is enough to rudely awake a medical epidemiologist in the middle of the night. It is a sobering development that the CDC has been concerned about for some time.
-
FDA Issues Alert on Devices
The FDA issued a June 1, 2016, alert that some of the Mycobacterium chimaera infections acquired by cardiothoracic patients in the U.S. may be linked to the Stöckert 3T Heater-Cooler System manufactured by the Sorin Group in Germany.